Meridiem Capital Partners LP Guardant Health, Inc. Transaction History
Meridiem Capital Partners LP
- $1.56 Trillion
- Q3 2025
A detailed history of Meridiem Capital Partners LP transactions in Guardant Health, Inc. stock. As of the latest transaction made, Meridiem Capital Partners LP holds 36,681 shares of GH stock, worth $3.46 Million. This represents 0.15% of its overall portfolio holdings.
Number of Shares
36,681
Previous 50,782
27.77%
Holding current value
$3.46 Million
Previous $2.64 Billion
13.28%
% of portfolio
0.15%
Previous 0.19%
Shares
2 transactions
Others Institutions Holding GH
# of Institutions
459Shares Held
125MCall Options Held
2.18MPut Options Held
2.69M-
Vanguard Group Inc Valley Forge, PA11.9MShares$1.12 Billion0.01% of portfolio
-
Black Rock Inc. New York, NY11.2MShares$1.06 Billion0.01% of portfolio
-
Baillie Gifford & CO5.13MShares$484 Million0.25% of portfolio
-
Invesco Ltd. Atlanta, GA4.93MShares$465 Million0.05% of portfolio
-
Capital International Investors Los Angeles, CA4.69MShares$443 Million0.05% of portfolio
About Guardant Health, Inc.
- Ticker GH
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 102,220,000
- Market Cap $9.65B
- Description
- Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...